RxDoctor Payments Data

Rajinder Singh, MD

Clinical Cardiac Electrophysiology · Marysville, CANPI 1184758799

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,908 of the $6,165 with a category attached, or 79.6%. 22 manufacturers reported payments, led by Biosense Webster, Inc. at 50.3% of the total. 2025 is the largest year on record at $2,282, 3.7 times the $611 reported in 2019. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in CA, where the typical reported total is $26,911.

$6,165in general payments, 2019–2025

Across 135 payments — averaging $45.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biosense Webster, Inc.$3K
  • Boston Scientific$612
  • ZOLL Respicardia, Inc.$421
  • Abbott$364
  • Medtronic$359
  • Biotronik Inc.$302
  • plus $1K from 16 others

What the payments were for

  • Travel & lodging$1,25720%
  • Food & beverage$4,90880%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,165 in reported general payments places this provider in the 15th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California →

Medicare billing

Part B allowed, 2024
$525,467
Medicare patients
882
Services billed
2,986

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban38$35,853
Amiodarone Hcl76$3,053
SotalolSotalol Hcl50$563
Flecainide Acetate12$551
Metoprolol Succinate46$371
Diltiazem 24hr Er (Cd)Diltiazem Hcl14$213
Metoprolol Tartrate26$139
Carvedilol14$51
Pantoprazole Sodium12$49

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$37$35,85338 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 290 clinical cardiac electrophysiology providers in California.

Other clinical cardiac electrophysiology in Marysville

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →